Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2) - PubMed (original) (raw)
Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2)
I Feoktistov et al. Biochem Pharmacol. 2001.
Abstract
The antiasthmatic drug enprofylline was the first known selective, though not potent, A(2B) antagonist. On the basis of structure-activity relationships (SARs) of xanthine derivatives, we designed a novel selective adenosine A(2B) receptor antagonist, 3-isobutyl-8-pyrrolidinoxanthine (IPDX), with potency greater than that of enprofylline. IPDX displaced [3H]ZM241385 ([3H]4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a]-[1,3,5]triazin-5-ylamino]ethyl)phenol) from human A(2B) adenosine receptors with a K(i) value of 470 +/- 2 nM and inhibited A(2B)-dependent cyclic AMP (cAMP) accumulation in human erythroleukemia (HEL) cells with a K(B) value of 625 +/- 71 nM. We found that IPDX was more selective than enprofylline toward human A(2B) receptors. It was 38-, 55-, and 82-fold more selective for human A(2B) than for human A(1) (K(i) value of 24 +/- 8 microM), human A(2A) (K(B) value of 36 +/- 8 microM), and human A(3) (K(i) value of 53 +/- 10 microM) adenosine receptors, respectively. IPDX inhibited NECA (5'-N-ethylcarboxamidoadenosine)-induced interleukin-8 secretion in human mast cells (HMC-1) with a potency close to that determined for A(2B)-mediated cAMP accumulation in HEL cells, thus confirming the role of A(2B) adenosine receptors in mediating human mast cell activation. Since adenosine triggers bronchoconstriction in asthmatic patients through human mast cell activation, IPDX may become a basis for the development of new antiasthmatic drugs with improved properties compared with those of enprofylline. Our data demonstrate that IPDX can be used as a tool to differentiate between A(2B) and other adenosine receptor-mediated responses.
Similar articles
- Proliferation, migration, and ERK activation in human retinal endothelial cells through A(2B) adenosine receptor stimulation.
Grant MB, Davis MI, Caballero S, Feoktistov I, Biaggioni I, Belardinelli L. Grant MB, et al. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2068-73. Invest Ophthalmol Vis Sci. 2001. PMID: 11481274 - Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.
Feoktistov I, Biaggioni I. Feoktistov I, et al. J Clin Invest. 1995 Oct;96(4):1979-86. doi: 10.1172/JCI118245. J Clin Invest. 1995. PMID: 7560091 Free PMC article. - The role of the adenosinergic system in lung fibrosis.
Della Latta V, Cabiati M, Rocchiccioli S, Del Ry S, Morales MA. Della Latta V, et al. Pharmacol Res. 2013 Oct;76:182-9. doi: 10.1016/j.phrs.2013.08.004. Epub 2013 Aug 28. Pharmacol Res. 2013. PMID: 23994158 Review. - Adenosine A2B receptors: a novel therapeutic target in asthma?
Feoktistov I, Polosa R, Holgate ST, Biaggioni I. Feoktistov I, et al. Trends Pharmacol Sci. 1998 Apr;19(4):148-53. doi: 10.1016/s0165-6147(98)01179-1. Trends Pharmacol Sci. 1998. PMID: 9612090 Review.
Cited by
- Myeloid cells in the tumor microenvironment: Role of adenosine.
Morello S, Pinto A, Blandizzi C, Antonioli L. Morello S, et al. Oncoimmunology. 2015 Dec 3;5(3):e1108515. doi: 10.1080/2162402X.2015.1108515. eCollection 2016 Mar. Oncoimmunology. 2015. PMID: 27141365 Free PMC article. Review. - Gs-coupled adenosine receptors differentially limit antigen-induced mast cell activation.
Hua X, Chason KD, Jania C, Acosta T, Ledent C, Tilley SL. Hua X, et al. J Pharmacol Exp Ther. 2013 Feb;344(2):426-35. doi: 10.1124/jpet.112.198978. Epub 2012 Nov 13. J Pharmacol Exp Ther. 2013. PMID: 23149337 Free PMC article. - Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells.
Ryzhov S, Novitskiy SV, Goldstein AE, Biktasova A, Blackburn MR, Biaggioni I, Dikov MM, Feoktistov I. Ryzhov S, et al. J Immunol. 2011 Dec 1;187(11):6120-9. doi: 10.4049/jimmunol.1101225. Epub 2011 Oct 28. J Immunol. 2011. PMID: 22039302 Free PMC article. - Recovery of respiratory activity after C2 hemisection (C2HS): involvement of adenosinergic mechanisms.
Nantwi KD. Nantwi KD. Respir Physiol Neurobiol. 2009 Nov 30;169(2):102-14. doi: 10.1016/j.resp.2009.07.014. Epub 2009 Aug 3. Respir Physiol Neurobiol. 2009. PMID: 19651244 Free PMC article. Review. - The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.
Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators. Alexander SP, et al. Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445. Br J Pharmacol. 2013. PMID: 24517644 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous